New Survey Assessment Finds Debilitating Impact of Thyroid Eye Disease (TED) on Quality of Life Continues Well Beyond Acute Disease into Chronic Phase
Go back to New Survey Assessment Finds Debilitating Impact of Thyroid Eye Disease (TED) on Quality of Life Continues Well Beyond Acute Disease into Chronic PhaseNational Health Partners, Inc. (NYSE: HPR) | Delayed: 4.73 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $4.73 | 52 Week High | $0.28 | |||
Open | $3.62 | 52 Week Low | $0.25 | |||
Day High | $4.73 | P/E | N/A | |||
Day Low | $4.73 | EPS | $-0.23 | |||
Volume | 3,248 |
HORIZON PHARMA (NASDAQ: HZNP) | Delayed: 116.30 --0 (-0%) | |||||
---|---|---|---|---|---|---|
Previous Close | $116.30 | 52 Week High | $23.44 | |||
Open | $116.30 | 52 Week Low | $13.06 | |||
Day High | $116.30 | P/E | N/A | |||
Day Low | $116.30 | EPS | $-0.96 | |||
Volume | 117 |